CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![GettyImages-1256602998-psychedelic-mindfulness]( "The Impact Of Expert PK/PD Modeling In Psychedelic Research")
The Impact Of Expert PK/PD Modeling In Psychedelic ResearchModel-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.
-
![FAIR data practices_GettyImages-1471413999]( "Modern Data Platform Strategies That Accelerate Clinical Development")
Modern Data Platform Strategies That Accelerate Clinical DevelopmentA modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.
-
![GettyImages-1499371064-money-sign-cost-rising-graph]( "The Real Cost In CNS Trials: Rater Drift And Site Readiness")
The Real Cost In CNS Trials: Rater Drift And Site ReadinessLearn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.
-
![GettyImages-2200128716-software-ai-machine-learning-percentages-code]( "Open-Source Technologies Within Data Sciences Functional Outsourcing")
Open-Source Technologies Within Data Sciences Functional OutsourcingAccelerate innovation in clinical trials by embracing open-source technologies that enhance data analysis, improve scalability, and unlock advanced predictive and machine-learning capabilities.
-
![GettyImages-1413755087-business-man-computer-data-workflow-automation]( "The True Cost Of Tool Sprawl")
The True Cost Of Tool SprawlTool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
-
Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy9/23/2025
Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Explore implementation strategies, lessons learned, and measurable results.
-
Revitalizing Recruitment In A Lupus Rescue Study9/11/2025
Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.
CENTRAL LABORATORIES PRODUCTS & SERVICES
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
Gain confidence in your clinical research data with direct data capture (DDC).
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.
It’s about time.
Modern eConsent.
Solved.
Deliver complex eConsent experiences that participants will love. Drive compliance and retention with truly informed participants, using a system that is easy to configure and manage from site to subject.
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
CENTRAL LABORATORIES SOLUTIONS
- RWD & Human Insight From Consulting & Analytics
- NDA/MAA Preparation Survival Guide: Overcoming Data Analysis Hurdles
- Technology Solutions And Services Tailored For Emerging Biopharma
- Customer-Centric, Cost-Effective, Quality-Focused Solutions
- Driving The Future Of Digital Clinical Trials
- The PPD Clinical Trial Forecasting Suite
- Clinical Data Review Analytics Solution
- Bring Your EDC Study In-House
- Lock Into Your Go-To Data Strategy
- Leverage AI To Optimize Protocol Design & Study Start-Up
VIDEOS
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
- AI Importer — See It in Action!
- Protect Personally Identifiable Information (PII) With My Medidata
NEWS
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns
- ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan
- Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture
- Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights
- PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research
- CORE 2025 - October 6-8, 2025
- Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift
- ISPOR Champions Research Transparency With Launch Of Open Science Badges
- Introducing Arcinova, A Quotient Sciences Company
- November 9-12: ISPOR Europe 2025: Powering Value And Access Through Patient-Centered Collaboration
- September 28-30: ISPOR Real-World Evidence Summit 2025: Through The Lens Of Asia Pacific
- September 10-11: Communicating HEOR For Maximum Impact, Influence, And Understanding